BrightAccountsProduction v1.0.0 v1.0.0 2024-06-10 The company was not dormant during the period The company was trading for the entire period Unaudited Accounts FRS 105 Accounts The principal activities of the company include the manufacture and sale of medical and dental instruments and equipment. 12 May 2026 1 NI716815 2025-06-30 NI716815 2024-06-09 NI716815 2024-06-10 2025-06-30 NI716815 uk-bus:PrivateLimitedCompanyLtd 2024-06-10 2025-06-30 NI716815 uk-curr:PoundSterling 2024-06-10 2025-06-30 NI716815 uk-bus:AbridgedAccounts 2024-06-10 2025-06-30 NI716815 uk-core:CapitalReserve 2025-06-30 NI716815 2024-06-10 2025-06-30 NI716815 uk-bus:Director1 2024-06-10 2025-06-30 NI716815 uk-bus:AuditExempt-NoAccountantsReport 2024-06-10 2025-06-30 NI716815 uk-bus:Micro-entities 2024-06-10 2025-06-30 xbrli:pure iso4217:GBP xbrli:shares

Simucare Ltd

Unaudited Financial Statements

for the financial period from 10 June 2024 (date of incorporation) to 30 June 2025

Simucare Ltd

Company Registration Number: NI716815

BALANCE SHEET

as at 30 June 2025

|  | Jun 25
|  | £
| Fixed Assets | 138
|  | ─────────
| Creditors: amounts falling due within one year | (7,207)
|  | ─────────
| Total Assets less Current Liabilities | (7,069)
| Accruals and deferred income | (850)
|  | ─────────
| Net Liabilities | (7,919)
|  | ═════════
| Capital and Reserves | (7,919)
|  | ═════════
| Notes to the Financial statements

1. | General Information
| Simucare Ltd is a private company limited by shares incorporated and registered in Northern Ireland. The registered number of the company is NI716815. The registered office of the company is 9 Ballyginniff Road, Aldergrove, Crumlin, Northern Ireland, BT29 4EF, which is also the principal place of business of the company. The financial statements have been presented in Pound (£) which is also the functional currency of the company. The financial statements cover the individual entity Simucare Ltd, for the financial period ended 30th June 2025.

2. | Going concern
| The company made a net loss of £7,920.00 during its first year of trading. The company is a start-up and is pre-revenue. Simucare Ltd is actively seeking investment under SEIS to support operations. The director has offered assurances that he will continue to financially support the company until such time as it receives investment. As such, the accounts are prepared on a going concern basis.

3. | Employees
| The average monthly number of employees, including director, during the financial period was
|  | Jun 25
|  | Number
| Director | 1
|  | ═════════

4. | Post-Balance Sheet Events
| There have been no significant events affecting the company since the financial period-end.

| For the financial period from 10 June 2024 (date of incorporation) to 30 June 2025 the company was entitled to exemption from audit under section 477 of the Companies Act 2006.
| The director confirms that the members have not required the company to obtain an audit of its financial statements for the financial period in question in accordance with section 476 of the Companies Act 2006.
| The director acknowledges their responsibilities for ensuring that the company keeps accounting records which comply with section 386 and for preparing financial statements which give a true and fair view of the state of affairs of the company as at the end of the financial period and of its profit and loss for the financial period in accordance with the requirements of sections 394 and 395 and which otherwise comply with the requirements of the Companies Act 2006 relating to financial statements, so far as applicable to the company.
| These financial statements have been prepared in accordance with the provisions available to micro-entities in Part 15 of the Companies Act 2006 and delivered in accordance with the provisions applicable to companies subject to the small companies' regime.
| The company has taken advantage of the exemption under section 444 not to file the Director's Report, Abridged Profit and Loss Account.
| Approved by the Director on 12 May 2026 and signed by:
| ________________________________ |
| Mr John Barber |
| Director |